Blood Lactate Analyzer

Blood Lactate Analyzer Market Outlook

The global Blood Lactate Analyzer market is anticipated to reach approximately USD 1.2 billion by 2035, expanding at a CAGR of around 8.5% during the forecast period from 2025 to 2035. This growth is driven by the increasing emphasis on sports medicine, the rising incidence of chronic diseases requiring critical care, and advancements in diagnostic technologies. Additionally, the growing trend of preventive healthcare and the demand for rapid diagnostic tools in clinical settings have further fueled the market's expansion. Technological advancements enabling miniaturization and portability of devices are also contributing significantly to the market's growth trajectory.

Growth Factor of the Market

One of the primary growth factors in the Blood Lactate Analyzer market is the increasing number of sports professionals and fitness enthusiasts who seek precise and quick assessments of their lactate levels to optimize performance and training regimens. Moreover, the rising prevalence of metabolic disorders and conditions such as diabetes and cardiovascular diseases necessitates effective monitoring and management, thus bolstering the demand for blood lactate analyzers in clinical diagnostics. The integration of advanced technologies, such as biosensors and wearable devices, is revolutionizing the market by providing real-time data and enhancing the user experience. Furthermore, the ongoing research in sports science for understanding lactate threshold and its incorporation in training programs is driving the application of blood lactate analyzers in sports medicine. The growing awareness about the importance of lactate testing in determining an athlete's performance and recovery is also contributing to the market's upward trend.

Key Highlights of the Market

• Projected growth at a CAGR of 8.5% from 2025 to 2035, reaching USD 1.2 billion.
• Increased applications in sports medicine and critical care environments.
• Technological advancements leading to portable and user-friendly devices.
• Growing demand for rapid diagnostic tools in clinical settings.
• Rising awareness of preventative healthcare measures among consumers.

By Product Type

Portable Blood Lactate Analyzer:

Portable blood lactate analyzers have become increasingly popular due to their convenience and ease of use, particularly in sports medicine and outdoor settings. These devices allow athletes to quickly assess their lactate levels on-site, enabling immediate adjustments to training intensity and recovery strategies. The compact design and battery-operated features enhance their usability in various environments, including field testing and remote locations. This segment is expected to exhibit significant growth as more athletes and coaches recognize the value of real-time feedback for optimizing performance. Furthermore, advancements in technology have reduced the size and increased the accuracy of portable devices, making them more accessible to both professionals and amateurs alike.

Bench-top Blood Lactate Analyzer:

Bench-top blood lactate analyzers are primarily utilized in laboratory settings where precision and accuracy are paramount. These devices are designed for high-throughput testing, making them ideal for use in hospitals and research institutions. They typically offer advanced features such as automated testing and integration with laboratory information systems, enhancing workflow efficiency. The demand for bench-top analyzers is driven by the need for reliable lactate testing in critical care settings, where timely diagnosis and treatment are essential. As healthcare providers increasingly focus on improving patient outcomes, the bench-top segment is expected to grow steadily, supported by ongoing innovations in laboratory technology.

Wearable Blood Lactate Analyzer:

Wearable blood lactate analyzers represent a cutting-edge innovation in the monitoring of lactate levels, providing users with continuous data in a non-invasive manner. These devices are designed for athletes seeking to optimize their training while minimizing disruption to their routine. By integrating lactate monitoring with other biometric data, wearables offer a comprehensive view of an athlete's performance and recovery state. The growing trend towards fitness tracking and health monitoring among consumers is expected to drive the adoption of wearable analyzers. As technology progresses, improvements in sensor accuracy and battery life will further enhance the appeal of these devices in the market.

Handheld Blood Lactate Analyzer:

Handheld blood lactate analyzers combine portability with ease of use, making them suitable for both clinical and sports applications. These devices are designed for on-the-go testing, providing quick results that are vital for athletic training and critical care scenarios. The demand for handheld analyzers is increasing as healthcare professionals and athletes alike seek more flexible options for monitoring lactate levels without the need for extensive laboratory setups. Their compact size and intuitive interfaces contribute to their growing popularity, particularly in emergency situations where rapid assessment is crucial. As more users become aware of the benefits of handheld devices, this segment is poised for significant growth in the coming years.

Laboratory Blood Lactate Analyzer:

Laboratory blood lactate analyzers are essential in clinical diagnostics, enabling accurate measurements of lactate levels in various medical conditions. These analyzers are typically larger and more complex than their portable counterparts, offering advanced features such as multiplex testing and high-throughput capabilities. The use of laboratory analyzers is critical for understanding metabolic disturbances in patients, leading to better management of conditions like sepsis and lactic acidosis. With the healthcare sector's ongoing focus on enhancing diagnostic accuracy and workflow efficiency, the laboratory blood lactate analyzer segment is likely to witness steady expansion, particularly as new technologies emerge to streamline operations.

By Application

Sports Medicine:

Sports medicine is one of the largest applications for blood lactate analyzers, as these devices allow for precise monitoring of athletes' performance, fatigue levels, and recovery. In this domain, lactate testing helps coaches and trainers understand the physiological responses of athletes during training and competitions. By measuring lactate levels, professionals can tailor training programs to maximize performance and minimize the risk of injury. The increasing focus on athlete health and performance optimization is anticipated to drive the demand for blood lactate analyzers in sports medicine. As awareness of the role of lactate in training and recovery continues to grow, this application is expected to see significant growth in the coming years.

Critical Care:

In critical care settings, blood lactate analyzers are crucial for diagnosing and managing patients with severe conditions, such as sepsis or shock, where timely intervention can be life-saving. Elevated lactate levels often indicate tissue hypoxia or metabolic distress, prompting healthcare providers to initiate rapid treatment protocols. The growing emphasis on evidence-based medicine and the need for immediate patient monitoring are significant drivers for the adoption of blood lactate analyzers in critical care units. As the healthcare industry continues to prioritize patient outcomes, the critical care application is poised for consistent growth, supported by advancements in medical technology.

Clinical Diagnostics:

Clinical diagnostics is another significant application of blood lactate analyzers, as they play a pivotal role in assessing metabolic conditions and guiding treatment. Laboratories utilize these analyzers to screen patients for various health issues, including liver disease and metabolic disorders. The increasing prevalence of chronic diseases globally necessitates efficient diagnostic tools, thereby driving the adoption of blood lactate analyzers in clinical settings. As healthcare providers strive for early detection and personalized treatment approaches, the clinical diagnostics segment is expected to expand rapidly, supported by technological innovations that enhance accuracy and speed of results.

Research:

Research institutions utilize blood lactate analyzers for various studies, including exercise physiology and metabolic health investigations. The ability to accurately measure lactate levels in different populations and conditions enables researchers to gain insights into metabolic processes and develop new interventions. As research continues to evolve, the demand for advanced blood lactate analyzers equipped with the latest technology is expected to grow. Furthermore, collaborations between universities and healthcare organizations to study lactate's role in health and disease will further fuel the growth of this application segment.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics remain the primary distribution channel for blood lactate analyzers, as these facilities are the main users of diagnostic tools in patient care. The increasing number of patients requiring metabolic assessments in emergency departments and critical care units significantly drives the demand for these devices. Healthcare providers seek reliable and efficient analyzers to facilitate rapid decision-making for patient management. Additionally, ongoing investments in healthcare infrastructure and technology are further bolstering the adoption of blood lactate analyzers in hospitals and clinics, ensuring that they remain the dominant distribution channel in the market.

Diagnostic Centers:

Diagnostic centers are becoming increasingly important as a distribution channel for blood lactate analyzers, particularly as patients seek specialized testing services. These centers often provide a range of diagnostic services, including metabolic testing, and require efficient equipment to meet the demand for timely results. The growth of outpatient diagnostic services, fueled by patient preferences for convenience and faster turnaround times, is expected to drive the adoption of blood lactate analyzers in diagnostic centers. As more patients utilize these facilities for routine testing, the significance of this distribution channel will continue to rise.

Sports Centers:

Sports centers represent a niche distribution channel for blood lactate analyzers, catering specifically to athletes and fitness enthusiasts. As the focus on performance optimization and health monitoring increases, sports centers are investing in specialized equipment to provide lactate testing services. The ability to offer immediate and precise feedback on athletes' lactate levels is a valuable asset for sports centers looking to enhance their services. The growing popularity of personalized training programs and the increasing number of individuals engaging in sports activities are expected to drive the adoption of blood lactate analyzers in these settings, making them an important distribution channel within the market.

Online Platforms:

Online platforms are becoming an increasingly viable distribution channel for blood lactate analyzers, particularly as e-commerce continues to grow in the healthcare sector. Consumers and healthcare providers are turning to online marketplaces to access a wider range of products, including blood lactate analyzers. The convenience of online shopping, combined with the ability to compare prices and features, is driving more customers toward digital purchasing options. As manufacturers and distributors enhance their online presence, the online platforms segment is expected to experience considerable growth, providing accessibility to a broader audience and contributing to the overall expansion of the market.

By Technology Type

Amperometric Biosensors:

Amperometric biosensors are widely used in blood lactate analyzers due to their high sensitivity and specificity in detecting lactate levels. These sensors work by measuring the electric current generated by the oxidation of lactate, allowing for rapid and accurate assessments. The technology is particularly beneficial in clinical settings where timely results are essential for patient management. The continued advancements in amperometric sensor technology are expected to drive innovation and improve the accuracy of lactate measurements, further enhancing its application in both clinical and sports medicine.

Fluorometric Biosensors:

Fluorometric biosensors utilize fluorescence-based detection methods to measure lactate concentrations in blood samples. This technology offers high sensitivity and the ability to detect low levels of lactate, making it suitable for both clinical diagnostics and research applications. The advantages of fluorometric biosensors include their rapid response times and minimal sample volume requirements, which are attractive features for healthcare providers and researchers alike. As the demand for precise and efficient diagnostic tools continues to grow, fluorometric biosensors are expected to gain traction in the blood lactate analyzer market.

Colorimetric Biosensors:

Colorimetric biosensors are another type of technology used in blood lactate analyzers, relying on color change reactions to indicate lactate levels. This method is easy to use and can be implemented in various settings, from clinical laboratories to on-site testing environments. The simplicity of colorimetric assays is appealing, especially as point-of-care testing becomes more prevalent. As more healthcare providers recognize the value of accessible and straightforward testing methods, colorimetric biosensors are expected to maintain a solid presence in the blood lactate analyzer market.

Chemiluminescent Biosensors:

Chemiluminescent biosensors are characterized by their ability to detect lactate through light emission resulting from a chemical reaction. This technology offers high sensitivity and specificity, making it suitable for various applications, including clinical diagnostics and research. The precision of chemiluminescent methods allows for accurate lactate measurements, which is critical for effective patient management. As healthcare providers increasingly seek reliable diagnostic solutions, the adoption of chemiluminescent biosensors in blood lactate analyzers is expected to rise.

Spectrophotometric Biosensors:

Spectrophotometric biosensors measure the absorbance of light at specific wavelengths to determine lactate concentrations in blood samples. This technology is valued for its accuracy and ability to analyze multiple parameters simultaneously. Spectrophotometric methods are particularly useful in laboratory settings where detailed metabolic assessments are required. As the demand for comprehensive diagnostic solutions grows, the use of spectrophotometric biosensors in blood lactate analyzers is likely to expand, supported by ongoing advancements in laboratory technology.

By Region

In North America, the blood lactate analyzer market is expected to dominate, accounting for over 40% of the global revenue share by 2035, primarily due to the presence of advanced healthcare infrastructure and a high prevalence of chronic diseases. The rising awareness of sports medicine and the increasing number of fitness enthusiasts contribute to the demand for blood lactate testing in this region. Moreover, the region is witnessing significant investments in healthcare technologies, further driving the growth of blood lactate analyzers. With a CAGR of approximately 8.0%, North America remains a key player in the market, reflecting its commitment to innovation and quality healthcare.

Europe is projected to be the second-largest market for blood lactate analyzers, capturing around 30% of the global market share by 2035. The region benefits from a robust healthcare system and an increasing emphasis on preventive healthcare measures, driving the demand for lactate testing in clinical settings. Factors such as the growth of research institutions and the rising popularity of sports activities contribute to the market's expansion in Europe. The European market is anticipated to grow at a CAGR of 9.2%, driven by advancements in technology and an increasing focus on personalized healthcare solutions. Meanwhile, the Asia Pacific region is expected to emerge as a significant market, with a growing healthcare infrastructure and increasing investments in health technology, driving the demand for blood lactate analyzers.

Opportunities

The blood lactate analyzer market presents numerous opportunities for growth, particularly in the realm of technological advancements. As innovation in medical technology continues to evolve, there is a growing potential for the development of more sophisticated and user-friendly analyzers that can cater to both clinical and sports applications. The integration of artificial intelligence and machine learning into blood lactate analyzers could lead to predictive analytics that informs athletes and healthcare providers about peak performance levels and necessary interventions. Moreover, the increasing popularity of home healthcare and point-of-care testing opens avenues for portable devices that facilitate lactate monitoring outside of traditional clinical environments, offering convenience to users and boosting market growth.

Another significant opportunity lies in the expanding application of blood lactate analyzers in emerging markets. Countries in Asia Pacific, Latin America, and the Middle East are witnessing improvements in their healthcare systems, leading to higher demand for advanced medical devices. As awareness regarding the importance of lactate monitoring in sports and health management grows, manufacturers have the chance to establish a presence in these regions. By adapting products to meet local needs and building partnerships with regional distributors and healthcare providers, companies can effectively tap into the burgeoning markets worldwide, solidifying their foothold in the global blood lactate analyzer landscape.

Threats

Despite the promising growth prospects for the blood lactate analyzer market, several threats could impact its trajectory. One significant concern is the increasing competition among manufacturers, leading to price wars that could erode profit margins. As new entrants continue to penetrate the market with innovative yet cost-effective solutions, established players may find it challenging to maintain their market share. Additionally, regulatory hurdles in different regions can pose challenges for companies seeking to introduce new products or expand their operations. Compliance with varying standards and regulations can increase the time and resources required for product development and market entry, potentially hampering overall growth.

Another threat to consider is the rapid pace of technological advancements, which can render existing products obsolete. As new technologies emerge, companies must continuously innovate and invest in research and development to keep pace with market demands. Failure to adapt to changing consumer preferences and technological innovations could lead to loss of market relevance. Furthermore, external factors such as economic downturns or shifts in healthcare policies may impact funding and investment in the healthcare sector, indirectly affecting the growth of the blood lactate analyzer market. As a result, organizations must remain vigilant and agile to navigate these potential challenges effectively.

Competitor Outlook

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Nova Biomedical
• Arkray, Inc.
• HemoCue AB
• EKF Diagnostics
• Randox Laboratories Ltd.
• Medtronic
• Amenity Health
• Dr. H. u. D. F. F. Schenk GmbH
• PerkinElmer, Inc.
• F. Hoffmann-La Roche AG
• Caretium Medical Technology Co., Ltd.
• QIAgen N.V.

The competitive landscape of the blood lactate analyzer market is characterized by a mix of established players and emerging companies, all striving to capture market share in this burgeoning sector. Leading organizations, such as Roche Diagnostics and Abbott Laboratories, leverage their extensive experience and well-established distribution networks to maintain a competitive edge. With a strong focus on research and development, these companies continuously innovate to enhance the performance and user-friendliness of their analyzers, addressing the growing demand for accurate and efficient lactate testing. Additionally, partnerships and collaborations with healthcare providers and research institutions are becoming increasingly common, as companies aim to expand their reach and improve their product offerings.

Emerging players, such as Caretium Medical Technology Co., Ltd. and Amenity Health, are making their mark in the blood lactate analyzer market by introducing innovative products that cater to the specific needs of healthcare providers and sports professionals. These companies often focus on niche segments, such as portable and wearable analyzers, to differentiate themselves from larger competitors. By emphasizing user experience and incorporating advanced technologies, these emerging players are steadily gaining traction in the market, contributing to a dynamic competitive environment. The blend of established and new players fosters innovation and drives advancements in the blood lactate analyzer landscape.

Furthermore, the competitive landscape is also shaped by the increasing emphasis on personalized healthcare and preventive medicine. Many companies are now focusing on developing analyzers that not only measure lactate levels but also provide insights into overall metabolic health. This trend is driven by the rising awareness among consumers regarding the benefits of monitoring their health metrics and optimizing their performance. Companies such as Nova Biomedical and EKF Diagnostics are at the forefront of this development, offering comprehensive testing solutions that cater to both clinical and sports applications. As the market evolves, those companies that successfully adapt to emerging trends and prioritize customer-centric innovations will likely thrive in the blood lactate analyzer market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 HemoCue AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 QIAgen N.V.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Arkray, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Amenity Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 EKF Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Nova Biomedical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 PerkinElmer, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Roche Diagnostics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Siemens Healthineers
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 F. Hoffmann-La Roche AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Randox Laboratories Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Dr. H. u. D. F. F. Schenk GmbH
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Caretium Medical Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Lactate Analyzer Market, By Application
    • 6.1.1 Sports Medicine
    • 6.1.2 Critical Care
    • 6.1.3 Clinical Diagnostics
    • 6.1.4 Research
  • 6.2 Blood Lactate Analyzer Market, By Product Type
    • 6.2.1 Portable Blood Lactate Analyzer
    • 6.2.2 Bench-top Blood Lactate Analyzer
    • 6.2.3 Wearable Blood Lactate Analyzer
    • 6.2.4 Handheld Blood Lactate Analyzer
    • 6.2.5 Laboratory Blood Lactate Analyzer
  • 6.3 Blood Lactate Analyzer Market, By Technology Type
    • 6.3.1 Amperometric Biosensors
    • 6.3.2 Fluorometric Biosensors
    • 6.3.3 Colorimetric Biosensors
    • 6.3.4 Chemiluminescent Biosensors
    • 6.3.5 Spectrophotometric Biosensors
  • 6.4 Blood Lactate Analyzer Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Diagnostic Centers
    • 6.4.3 Sports Centers
    • 6.4.4 Online Platforms

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Blood Lactate Analyzer Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Lactate Analyzer market is categorized based on

By Product Type

• Portable Blood Lactate Analyzer
• Bench-top Blood Lactate Analyzer
• Wearable Blood Lactate Analyzer
• Handheld Blood Lactate Analyzer
• Laboratory Blood Lactate Analyzer

By Application

• Sports Medicine
• Critical Care
• Clinical Diagnostics
• Research

By Distribution Channel

• Hospitals & Clinics
• Diagnostic Centers
• Sports Centers
• Online Platforms

By Technology Type

• Amperometric Biosensors
• Fluorometric Biosensors
• Colorimetric Biosensors
• Chemiluminescent Biosensors
• Spectrophotometric Biosensors

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Nova Biomedical
• Arkray, Inc.
• HemoCue AB
• EKF Diagnostics
• Randox Laboratories Ltd.
• Medtronic
• Amenity Health
• Dr. H. u. D. F. F. Schenk GmbH
• PerkinElmer, Inc.
• F. Hoffmann-La Roche AG
• Caretium Medical Technology Co., Ltd.
• QIAgen N.V.